Found Best Alternatives for Each Use Case

What Found Actually Offers

Found operates as a subscription telehealth platform that matches patients with clinicians who can prescribe FDA-approved weight-loss medications. The program bundles asynchronous provider messaging, a mobile app for habit tracking, and optional behavioral coaching into a monthly fee.

Medication Tiers and Pricing

Found uses a tiered pricing model. The lowest tier (around $99/month) typically covers older generics like metformin or bupropion-naltrexone. GLP-1 prescriptions, including semaglutide and tirzepatide, sit at higher tiers that can exceed $399/month before medication costs. Patients on select Blue Cross Blue Shield plans may have portions covered, but most GLP-1 users pay out of pocket for the drug itself.

Clinical Model

The Found clinical model relies on asynchronous messaging with a provider rather than scheduled video visits. This works well for straightforward prescription renewals. It is less suited for patients who need detailed metabolic workups or have complex comorbidities like type 2 diabetes alongside obesity. Found does not order labs directly; patients must arrange bloodwork through their primary care physician or a third-party lab service.

A 2024 retrospective cohort study published in Obesity found that telehealth-initiated GLP-1 therapy produced comparable 6-month weight loss to in-clinic prescriptions, with a mean difference of only 0.8 percentage points [3]. The delivery model matters less than medication adherence and dose titration.

Is Found Legit?

Found is a licensed telehealth company operating in all 50 U.S. States. Its clinicians hold valid DEA registrations and state medical licenses. The platform has prescribed FDA-approved medications since 2020 and partnered with select BCBS affiliates for covered weight-management benefits.

What the Evidence Supports

The drugs Found prescribes are well studied. Semaglutide 2.4 mg (Wegovy) earned FDA approval based on the STEP program, where STEP-1 (N=1,961) demonstrated 14.9% mean body-weight reduction at 68 weeks versus 2.4% with placebo [1]. Tirzepatide (Zepbound) demonstrated even greater efficacy in SURMOUNT-1 (N=2,539), with the 15 mg dose producing 22.5% mean weight loss at 72 weeks [2].

Where Found Falls Short

Found's legitimacy as a prescriber is not in question. The gap is in wraparound care. The platform does not include body composition tracking via DEXA, routine metabolic panels, or structured dietary protocols. Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women's Hospital, has stated: "Medication alone is only half the equation. Without structured lifestyle modification, patients regain 50 to 70 percent of lost weight within two years of stopping GLP-1 therapy" [4].

That quote frames why alternatives with stronger coaching infrastructure may produce more durable results for certain patients.

How to Choose the Right Alternative

Not every Found competitor suits every patient. The right choice depends on four variables: insurance coverage, preferred medication, budget, and how much structured support you want.

The HealthRX 4-Factor Decision Framework

Factor 1: Insurance status. If your employer plan covers GLP-1s for obesity, Calibrate or a direct primary-care prescriber will minimize out-of-pocket cost. If you are cash-pay, compounded semaglutide programs (HealthRX, Ro Body) offer the lowest monthly spend.

Factor 2: Drug preference. Patients who want branded tirzepatide (Zepbound) need a platform with Eli Lilly supply-chain access. Ro Body and Sequence both carry it. Found carries it at a premium tier. If compounded semaglutide is acceptable, HealthRX programs start at $199/month all-in.

Factor 3: Budget ceiling. Monthly costs across platforms range from $99 (generic-only tiers) to $1,500+ (branded GLP-1 plus coaching). Set a ceiling before comparing. A platform that costs $200/month but includes labs and coaching may deliver better per-dollar value than one at $99/month that requires you to arrange (and pay for) labs separately.

Factor 4: Coaching depth. Found offers app-based behavioral nudges. Calibrate provides a structured 12-month curriculum with a dedicated coach. HealthRX pairs prescriptions with quarterly metabolic reviews. Match the intensity to your self-management confidence.

Found vs. Calibrate

Calibrate markets itself as a "metabolic reset" program. It bundles a 12-month structured curriculum, one-on-one video coaching sessions, and GLP-1 prescriptions into a single annual fee (approximately $1,500 to $1,900 for the program, medication separate).

Strengths Over Found

Calibrate requires baseline labs (HbA1c, lipid panel, metabolic panel) before prescribing and repeats them at 6 and 12 months. This gives both the patient and the clinician objective metabolic data. Found does not build labs into its workflow.

Calibrate's coaching model uses scheduled video sessions rather than asynchronous chat. For patients who struggle with self-directed behavior change, this accountability structure may improve adherence. A 2023 analysis in The Lancet Diabetes & Endocrinology showed that structured behavioral intervention added 4.1 percentage points of weight loss on top of GLP-1 pharmacotherapy alone over 12 months [5].

Weaknesses vs. Found

Calibrate's upfront annual fee creates a higher barrier to entry. Found's monthly subscription allows patients to start, pause, or cancel with less financial commitment. Calibrate also has a narrower formulary, historically favoring semaglutide over tirzepatide, though this has expanded in 2026.

Found vs. Ro Body

Ro Body (formerly Ro Weight Loss) operates through the Ro telehealth system. It offers synchronous video visits, direct lab ordering through Quest Diagnostics partnerships, and access to both branded and compounded GLP-1 medications.

Strengths Over Found

Ro Body's integrated lab ordering removes one of Found's biggest friction points. Patients can get a metabolic panel, thyroid function test, and HbA1c drawn at a Quest location without involving their primary care provider. Pricing for compounded semaglutide through Ro Body has been as low as $145/month during promotional periods, though standard pricing sits around $299/month.

Ro Body also offers a broader formulary. In addition to semaglutide and tirzepatide, patients can access liraglutide (generic Saxenda equivalent), metformin, and combination regimens.

Weaknesses vs. Found

Ro Body's coaching component is thinner than Found's app-based system. Ro focuses on medical management rather than behavior change. Patients who want daily habit tracking, community features, or structured meal guidance will find Found's app more engaging.

Found vs. Sequence

Sequence is a GLP-1-focused telehealth platform that emphasizes insurance navigation. Its core value proposition: Sequence's care team handles prior authorizations, appeals, and insurance billing for GLP-1 prescriptions.

Best For

Patients with commercial insurance that covers anti-obesity medications but requires prior authorization. Sequence reports a 92% prior-authorization approval rate on first submission, compared to an industry average below 60% [6]. If your insurance technically covers Wegovy or Zepbound but your doctor's office lacks the bandwidth to fight for approval, Sequence fills that gap.

Limitations

Sequence does not offer non-GLP-1 medications. If a clinician determines that bupropion-naltrexone (Contrave) or topiramate-phentermine (Qsymia) is more appropriate, Sequence cannot prescribe them. Found can.

Found vs. HealthRX

HealthRX offers GLP-1 programs that bundle compounded semaglutide or tirzepatide with quarterly metabolic reviews, body-composition tracking, and provider-ordered labs. The model sits between Found's lightweight subscription and Calibrate's intensive 12-month curriculum.

Strengths Over Found

HealthRX programs include baseline and quarterly labs (comprehensive metabolic panel, HbA1c, lipid panel, thyroid panel) in the program fee. The clinical team reviews results and adjusts dosing during scheduled video consultations rather than asynchronous chat. Programs start at $199/month for compounded semaglutide including medication, labs, and provider visits.

The 2022 Endocrine Society Clinical Practice Guideline on pharmacological management of obesity recommends periodic metabolic monitoring for all patients on anti-obesity pharmacotherapy, including fasting glucose, lipids, and hepatic function [7]. HealthRX builds this into the default workflow. Found leaves it to the patient.

Weaknesses vs. Found

HealthRX does not offer the app-based behavioral coaching or community features that Found provides. Patients who value daily engagement through a mobile app may prefer Found's interface. HealthRX also does not accept insurance for the program fee (though patients can submit superbills for potential reimbursement).

Cost Comparison Table

| Platform | Monthly program fee | GLP-1 medication cost | Labs included | Coaching model | |---|---|---|---|---| | Found | $99 to $399 | Separate (varies) | No | App-based, async | | Calibrate | ~$150/mo (annual) | Separate (varies) | Yes (baseline + 6/12 mo) | Video, structured | | Ro Body | $99 to $299 | Included in some tiers | Yes (Quest partner) | Minimal | | Sequence | $99 | Billed to insurance | No | Async messaging | | HealthRX | From $199 | Included (compounded) | Yes (quarterly) | Video, quarterly |

Branded Wegovy (semaglutide 2.4 mg) carries a list price of $1,349.02 per month [8]. Branded Zepbound (tirzepatide) lists at $1,059.87 per month [9]. Compounded versions, where available through 503B outsourcing facilities, typically run $150 to $450/month depending on dose. The FDA's current enforcement discretion policy on compounded GLP-1s remains in effect as of May 2026 for semaglutide, while tirzepatide compounding eligibility depends on ongoing shortage status determinations [10].

Who Should Stay With Found

Found is a reasonable choice for patients who want a low-commitment entry point into medicated weight loss. The monthly subscription model, broad formulary (GLP-1 and non-GLP-1 options), and BCBS partnerships make it accessible.

Best-Fit Patient Profile

The ideal Found patient is someone with straightforward obesity (BMI 30+ or BMI 27+ with a comorbidity), no complex metabolic conditions requiring frequent lab monitoring, existing access to a primary care provider for bloodwork, and a preference for self-directed behavior change supported by app-based tools.

If you need insurance navigation, consider Sequence. If you need structured coaching with lab oversight, consider Calibrate or HealthRX. If you want the lowest cash-pay price for compounded GLP-1 medication, compare Ro Body and HealthRX directly.

The American Gastroenterological Association's 2024 Clinical Practice Guideline on pharmacological management of obesity recommends that clinicians "select anti-obesity pharmacotherapy based on patient preference, comorbidity profile, drug interactions, and cost" [11]. No single telehealth platform is best for everyone. The right alternative to Found depends on which of those four factors matters most to you.